Explore the connection between gut nerves, intuition, and gut health through a study on Anti-Gephron Antibodies in systemic sclerosis. Discover how antibodies in the gastrointestinal tract impact gut function and potential biomarkers for lower GI disease. Hear about a rheumatologist's career journey and insights on transitioning to an independent investigator. Learn about the challenges and importance of a supportive network when moving institutions.
Identifying novel anti-ENS autoantibodies can aid in clinical phenotyping of GI dysfunction in systemic sclerosis.
The unique Wnt-Cre Td Tomato mouse model helps in understanding the distribution of autoantigens in enteric neurons.
Deep dives
Identification of Novel Antibodies in Scleroderma Gastrointestinal Disease
Research focused on identifying previously undefined antibodies in Scleroderma-related gastrointestinal disease to explore correlations between antibodies and gut function, potentially indicating target autoantigens for new therapies.
Importance of the Mouse Model in Antibody Discovery
The unique Wnt-Cre Td Tomato mouse model was crucial in labeling neural crest-derived cells in the gastrointestinal tract, assisting in understanding the distribution and expression of autoantigens, especially in enteric neurons, not easily accessible in human studies.
Significance of Anti-Gefron Antibodies in Clinical Practice
Anti-Gefron antibodies show promise as potential biomarkers for identifying high-risk patients for GI disease progression in Scleroderma, paving the way for future diagnostic and therapeutic advancements in the clinical management of the condition.
Welcome back to “Journals”! Our topic of discussion today comes from the manuscript Anti-Gephyrin Antibodies: A Novel Specificity in Patients With Systemic Sclerosis and Lower Bowel Dysfunction and our guest today is the study’s first author, Dr. Zsuzsanna McMahan. The study recognizes that the enteric nervous system (ENS) regulates the gastrointestinal (GI) function, which is commonly impaired in those who suffer from systemic sclerosis (SSc). Dr. McMahan and her team’s objective for this study was “to identify novel anti-ENS autoantibodies with an aim to clinically phenotype SSc GI dysfunction”. We sit down with Dr. McMahan and discuss the study’s methods and discoveries. Plus, her experience transitioning from a junior to an independent investigator and what advice she can offer our young listeners for the journey along the way.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode